About
Syndeio Biosciences develops synapse-targeted therapies for neuropsychiatric and cognitive disorders by leveraging a proprietary pharmacology platform to enhance synaptic function and brain health.
Explore Syndeio Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.